Exelon is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Rivastigmine.
Product ID | 0078-0501_2e2200d5-3ab6-4b69-a1e0-12d84a4a7b43 |
NDC | 0078-0501 |
Product Type | Human Prescription Drug |
Proprietary Name | Exelon |
Generic Name | Rivastigmine |
Dosage Form | Patch, Extended Release |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2007-07-06 |
Marketing Category | NDA / NDA |
Application Number | NDA022083 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | RIVASTIGMINE |
Active Ingredient Strength | 5 mg/24h |
Pharm Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2007-07-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022083 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-09-14 |
Marketing Category | NDA |
Application Number | NDA022083 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-07-06 |
Ingredient | Strength |
---|---|
RIVASTIGMINE | 4.6 mg/24h |
SPL SET ID: | 07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0323 | Exelon | rivastigmine tartrate |
0078-0324 | Exelon | rivastigmine tartrate |
0078-0325 | Exelon | rivastigmine tartrate |
0078-0326 | Exelon | rivastigmine tartrate |
0078-0501 | Exelon | rivastigmine |
0078-0502 | Exelon | rivastigmine |
0078-0503 | Exelon | rivastigmine |
21695-357 | Exelon | Exelon |
0378-9070 | Rivastigmine | rivastigmine |
0378-9071 | Rivastigmine | rivastigmine |
0378-9072 | Rivastigmine | rivastigmine |
0781-7304 | Rivastigmine | rivastigmine |
0781-7309 | Rivastigmine | rivastigmine |
0781-7313 | Rivastigmine | rivastigmine |
16714-115 | Rivastigmine | Rivastigmine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXELON 97977525 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 97977523 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 97110038 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 97110036 not registered Live/Pending |
Exelon Corporation 2021-11-05 |
EXELON 86776336 5508909 Live/Registered |
Exelon Corporation 2015-10-02 |
EXELON 86776333 5508908 Live/Registered |
Exelon Corporation 2015-10-02 |
EXELON 86302338 4671120 Live/Registered |
Exelon Corporation 2014-06-06 |
EXELON 85982666 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |
EXELON 85982665 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |
EXELON 85980324 4445212 Live/Registered |
Exelon Corporation 2012-05-24 |
EXELON 85980323 4445211 Live/Registered |
Exelon Corporation 2012-05-24 |
EXELON 85634507 not registered Dead/Abandoned |
Exelon Corporation 2012-05-24 |